Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lucky Iron Fish Home Fortification of Iron

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02341586
Recruitment Status : Completed
First Posted : January 19, 2015
Last Update Posted : March 16, 2018
Sponsor:
Collaborators:
NCHADS - Ministry of Health of Cambodia
University of Guelph
Information provided by (Responsible Party):
Tim Green, University of British Columbia

Brief Summary:
The purpose of this research is to determine if cooking with an iron ingot called the Lucky Iron Fish (LIF) increases the hemoglobin status in women of childbearing age living in Preah Vihear, Cambodia. The investigators hypothesize that the use of the LIF during cooking over a 12-month period will be as efficacious at increasing hemoglobin concentration as iron supplements (18 mg elemental iron) and will be more efficacious than the control.

Condition or disease Intervention/treatment Phase
Anemia Anemia, Iron-Deficiency Hemoglobinopathies Other: Lucky Iron Fish - home fortification system Dietary Supplement: 18 mg elemental iron Other: Nutrition Education Not Applicable

Detailed Description:

Background: Anemia is prevalent in Cambodia, affecting ~44% of women. The causes of anemia are multifactorial. Globally, the most common form is iron deficiency anemia (IDA), which can lead to adverse perinatal health outcomes. In Cambodia, there is evidence that suggests hemoglobinopathies (genetic hemoglobin [Hb] disorders) are prevalent (~50%) and are a major contributor to anemia. In Preah Vihear province, Cambodia, the estimated prevalence of malaria is ~12.3%. Malaria contributes to anemia through a decrease in the production of red blood cells, and an increased destruction of red blood cells.

In Cambodia, iron supplements are recommended to treat anemia, however there is evidence of low compliance among women. The use of cast iron pots has proven to be an effective alternative to prevent and reduce IDA in developing countries. However, cast iron pots are not commonly used in Cambodia because they are expensive, difficult to clean, and heavy. A novel alternative is the Lucky Iron Fish (LIF), which is an iron ingot used during cooking as an in-home fortification system of iron transfer. The LIF ingot is small, lightweight, and easy to clean. Previous research in Cambodia confirmed the acceptance of the LIF to be high, but findings from this study were inconclusive and had several limitations.

Objective: The primary objective of this study is to determine the efficacy of the LIF to increase Hb concentration in Cambodian women of reproductive age.

Methods: A total of 330 women (18-49 y) with mild or moderate anemia (Hb 80-120 g/L) from rural Preah Vihear, Cambodia will be recruited to one of three arms to receive LIF, 18 mg elemental iron, or a placebo. Women with severe anemia will be excluded and referred for treatment. All three groups will receive nutrition education. Monitoring will be conducted monthly to measure compliance.

A trained, Khmer-speaking interviewer will meet with the women to explain the details of the study as per the consent form. Once consent is obtained the trained interviewer will measure hemoglobin status using a hemocue device to confirm eligibility of the study. If eligible, the trained interviewer will then administer the baseline questionnaire in the participant's home.

The questionnaire will collect demographic data, as well as information on current dietary intake, drinking water treatment, knowledge of iron deficiency anemia, knowledge of malaria, and perceptions of supplement use.

Participants will have a venous blood sample taken at 0, 6, and 12 months and analyzed for hemoglobin and multiple biomarkers of iron status (e.g. soluble transferrin receptor, ferritin, and retinol binding protein (RBP)). Ferritin will be corrected for inflammation using measures of alpha-1 acid glycoprotein (AGP, g/L) and C-reactive protein (CRP, mg/L) which are biomarkers of chronic and acute inflammation, respectively.

Genotyping will be conducted to determine the prevalence of hemoglobinopathies among women. The prevalence of malaria in this cohort will be determined using rapid diagnostic test kits for P. Falciparum, and P. Vivax at baseline, midline, and endline.

Potential Significance: The LIF has the potential to be a low cost, effective and simple-to-use product to prevent and reduce iron deficiency anemia in Cambodia.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 340 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: A Randomized Control Trial of the Lucky Iron Fish to Improve Hemoglobin Concentration in Women in Preah Vihear, Cambodia
Study Start Date : April 2015
Actual Primary Completion Date : May 2016
Actual Study Completion Date : May 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Iron

Arm Intervention/treatment
Experimental: Lucky Iron Fish
This group will receive a Lucky Iron Fish to use during cooking.
Other: Lucky Iron Fish - home fortification system
The Lucky Iron Fish (LIF) is an ingot used during cooking as an in-home fortification system of iron. The LIF works on the same principle as cast iron pots and pans by increasing dietary intake of iron but is small and lightweight. The LIF was designed in collaboration with village elders and community members to ensure it would be accepted in Cambodia. The iron ingot resembles a local fish believed to be lucky among villages in Cambodia, contributing to the acceptability of the ingot.

Active Comparator: 18 mg iron
This group will receive a daily oral iron supplement.
Dietary Supplement: 18 mg elemental iron
This dose of iron is the recommend dietary allowance (RDA) for iron for this cohort. Women will receive one-on-one instructions on how best to consume their tablet (for example, with food).

Control group
This group will receive nutrition education
Other: Nutrition Education
This group will receive education containing key messages around anemia, malaria, iron intake, and dietary diversity.




Primary Outcome Measures :
  1. hemoglobin concentration at endline [ Time Frame: 12 months ]

Secondary Outcome Measures :
  1. Change in ferritin concentration [ Time Frame: Baseline (t=0), midline (t=6 months), and endline (t=12 months) ]
    Ferritin is a biomarker of iron status. Ferritin will be corrected with measures using measures of alpha-1 acid glycoprotein and C-reactive protein.

  2. Number of women in Preah Vihear, Cambodia with a genetic hemoglobin disorder [ Time Frame: Midline (t=6 months) ]
  3. How the prevalence of malaria changes in women living in Preah Vihear Cambodia over one year [ Time Frame: Baseline (t=0), midline (t=6 months), and endline (t=12 months) ]
  4. Change in soluble transferrin receptor (sTfR) concentration [ Time Frame: Baseline (t=0), midline (t=6 months), and endline (t=12 months) ]
    sTfR is a biomarker of iron status



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 49 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Mild or Moderate Anemia [Hb 80-119]
  • Willing to provide a fingerprick sample of blood at baseline
  • Willing to provide 10 mL of venous blood at 0, 6 & 12 months
  • Not planning on moving in the next 12 months
  • Not participating in any other nutrition intervention
  • Be able to provide written and information consent

Exclusion Criteria:

  • Be ill or taking any medications [Hb < 80]
  • Have normal Hb status [Hb > 120]
  • Currently consuming or planning to consume Fe supplements in the next 12 months
  • Pregnant (based on self report)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02341586


Locations
Layout table for location information
Cambodia
Rovieng Health Centre
Rovieng, Preah Vihear, Cambodia
Sponsors and Collaborators
University of British Columbia
NCHADS - Ministry of Health of Cambodia
University of Guelph
Investigators
Layout table for investigator information
Principal Investigator: Tim J Green, PhD University of British Columbia
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Tim Green, Principle Investigator, University of British Columbia
ClinicalTrials.gov Identifier: NCT02341586    
Other Study ID Numbers: H14-02551
First Posted: January 19, 2015    Key Record Dates
Last Update Posted: March 16, 2018
Last Verified: March 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Keywords provided by Tim Green, University of British Columbia:
Malaria
Cambodia
Iron
Childbearing Age
Women
Home Fortification
Additional relevant MeSH terms:
Layout table for MeSH terms
Anemia
Anemia, Iron-Deficiency
Hemoglobinopathies
Hematologic Diseases
Anemia, Hypochromic
Iron Metabolism Disorders
Metabolic Diseases
Genetic Diseases, Inborn
Iron
Trace Elements
Micronutrients
Nutrients
Growth Substances
Physiological Effects of Drugs